Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP study according OECD / EU guideline

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(4-methylpentan-2-yl)aniline
EC Number:
700-095-5
Cas Number:
203448-76-4
Molecular formula:
C12 H19 N
IUPAC Name:
2-(4-methylpentan-2-yl)aniline

In vivo test system

Test animals

Species:
mouse
Strain:
NMRI
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
0%, 2 %, 10% and 50% v/v
No. of animals per dose:
6

Results and discussion

In vivo (LLNA)

Results
Parameter:
SI
Remarks on result:
other: 0%: 1.0 2%: 0.76 10%: 0.7 50%: 1.03

Any other information on results incl. tables

Based on results obtained in validation studies and general experiences with this test system groups of mice were treated with vehicle, 2%, 10% or 50% in A/OO.

The NMRJ mice did not show an increase in the stimulation indices for cell counts or for weights of the draining lymph nodes after application of the test item.

The "positive level" which is 1.4 for the cell count index was never reached or exceeded in any dose group.

The "positive level" of ear swelling, which is 0.02 mm increase , i.e. about 10% of the control values, has not been reached or exceeded in any dose group.

No substance specific effects were determined for ear weights either.

On day 4 a slight statistically significant increase in ear swelling had been determined for group 3 and a slight statistically significant decrease in ear weights had been determined for group 4. These changes are, however, within the normal range of variance for these

parameters, which means that it is only of statistical significance because the mathematical conditions were favorable.

No other substance specific effects were determined.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
This study does neither point to a non-specific (irritant) nor to a specific immunostimulating (sensitizing) potential of the test item.